Chemclin Diagnostics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	332.68	436.29	445.34	465.27	470.77
Revenue Growth (YoY)	-23.75%	-2.03%	-4.28%	-1.17%	12.57%
Cost of Revenue	111.52	113.12	110.56	121.11	119.84
Gross Profit	221.16	323.17	334.78	344.16	350.94
Selling, General & Admin	105.04	136.61	133.41	135.17	143.23
Research & Development	73.31	73.74	65.14	68.36	66.78
Other Operating Expenses	-3.75	5.38	5.03	5.49	3.66
Operating Expenses	174.61	215.53	203.17	209.05	213.82
Operating Income	46.55	107.65	131.61	135.11	137.12
Interest Expense	-	-5.24	-0.47	-0.52	-0.73
Interest & Investment Income	8.84	19.79	22.04	25.03	18.29
Currency Exchange Gain (Loss)	-	0.07	0.08	0.4	-0.13
Other Non Operating Income (Expenses)	2.84	-0.09	-0.15	-0.08	-0.42
EBT Excluding Unusual Items	58.24	122.18	153.12	159.93	154.13
Gain (Loss) on Sale of Investments	1.22	-	-	-	-
Gain (Loss) on Sale of Assets	0.12	0.06	0.14	-0.62	-0.64
Asset Writedown	-9.76	-3.67	-2.8	-1.46	-0.32
Other Unusual Items	-	19.35	15.66	19.51	9.02
Pretax Income	49.82	137.92	166.12	177.37	162.19
Income Tax Expense	5.91	10.84	18.75	24.74	19.43
Net Income	43.91	127.07	147.37	152.63	142.76
Net Income to Common	43.91	127.07	147.37	152.63	142.76
Net Income Growth	-65.44%	-13.77%	-3.44%	6.91%	21.99%
Shares Outstanding (Basic)	399	397	398	402	386
Shares Outstanding (Diluted)	399	397	398	402	386
Shares Change (YoY)	0.53%	-0.30%	-0.83%	4.10%	8.80%
EPS (Basic)	0.11	0.32	0.37	0.38	0.37
EPS (Diluted)	0.11	0.32	0.37	0.38	0.37
EPS Growth	-65.63%	-13.51%	-2.63%	2.70%	12.12%
Free Cash Flow	24.01	60.46	-128.32	119.28	116.31
Free Cash Flow Per Share	0.06	0.15	-0.32	0.30	0.30
Dividend Per Share	-	0.125	0.125	0.347	0.170
Dividend Growth	-	-	-63.98%	104.12%	-
Gross Margin	66.48%	74.07%	75.17%	73.97%	74.54%
Operating Margin	13.99%	24.67%	29.55%	29.04%	29.13%
Profit Margin	13.20%	29.13%	33.09%	32.80%	30.32%
Free Cash Flow Margin	7.22%	13.86%	-28.81%	25.64%	24.71%
EBITDA	93.49	153.7	168.77	175.19	179.97
EBITDA Margin	28.10%	35.23%	37.90%	37.65%	38.23%
D&A For EBITDA	46.94	46.05	37.16	40.08	42.84
EBIT	46.55	107.65	131.61	135.11	137.12
EBIT Margin	13.99%	24.67%	29.55%	29.04%	29.13%
Effective Tax Rate	11.86%	7.86%	11.29%	13.95%	11.98%
Revenue as Reported	-	436.29	445.34	465.27	470.77
Advertising Expenses	-	4.06	6.63	4.1	6.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.